152.65
0.96%
1.45
Dopo l'orario di chiusura:
152.65
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$151.20
Aprire:
$151.31
Volume 24 ore:
1.10M
Relative Volume:
1.38
Capitalizzazione di mercato:
$17.04B
Reddito:
$9.54B
Utile/perdita netta:
$841.00M
Rapporto P/E:
20.52
EPS:
7.44
Flusso di cassa netto:
$1.02B
1 W Prestazione:
-0.22%
1M Prestazione:
-0.29%
6M Prestazione:
+4.55%
1 anno Prestazione:
+15.15%
Quest Diagnostics Inc Stock (DGX) Company Profile
Nome
Quest Diagnostics Inc
Settore
Industria
Telefono
(973) 520-2700
Indirizzo
500 PLAZA DRIVE, SECAUCUS
Confronta DGX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
152.65 | 17.04B | 9.54B | 841.00M | 1.02B | 7.44 |
TMO
Thermo Fisher Scientific Inc
|
573.06 | 219.20B | 42.37B | 6.14B | 7.78B | 15.95 |
DHR
Danaher Corp
|
244.11 | 176.31B | 23.74B | 3.89B | 4.98B | 5.24 |
A
Agilent Technologies Inc
|
152.57 | 43.57B | 6.51B | 1.29B | 1.37B | 4.42 |
IQV
Iqvia Holdings Inc
|
205.69 | 37.33B | 15.32B | 1.41B | 1.96B | 7.62 |
IDXX
Idexx Laboratories Inc
|
427.33 | 34.99B | 3.84B | 866.24M | 792.60M | 10.37 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-06 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
2024-12-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2024-12-10 | Ripresa | Jefferies | Buy |
2024-10-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2024-08-28 | Ripresa | Evercore ISI | In-line |
2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
2024-02-26 | Iniziato | Leerink Partners | Market Perform |
2024-02-07 | Aggiornamento | Jefferies | Hold → Buy |
2024-01-03 | Iniziato | Barclays | Equal Weight |
2023-12-12 | Aggiornamento | BofA Securities | Neutral → Buy |
2023-06-29 | Iniziato | Piper Sandler | Neutral |
2023-05-02 | Downgrade | BofA Securities | Buy → Neutral |
2023-04-03 | Aggiornamento | Citigroup | Sell → Neutral |
2023-01-23 | Iniziato | Evercore ISI | In-line |
2022-11-17 | Downgrade | Citigroup | Neutral → Sell |
2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
2022-04-04 | Downgrade | Citigroup | Buy → Neutral |
2022-02-23 | Downgrade | UBS | Buy → Neutral |
2022-02-02 | Downgrade | Jefferies | Buy → Hold |
2022-01-28 | Downgrade | Deutsche Bank | Buy → Hold |
2021-05-04 | Aggiornamento | UBS | Neutral → Buy |
2021-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
2020-10-21 | Aggiornamento | Argus | Hold → Buy |
2020-07-29 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-07-14 | Aggiornamento | BofA Securities | Neutral → Buy |
2020-06-09 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
2020-06-02 | Aggiornamento | Deutsche Bank | Hold → Buy |
2020-04-28 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2020-04-27 | Aggiornamento | Citigroup | Neutral → Buy |
2020-04-27 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
2020-03-27 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-01-08 | Iniziato | Wells Fargo | Underweight |
2020-01-07 | Downgrade | Barclays | Overweight → Equal Weight |
2019-12-19 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
2019-07-15 | Downgrade | Goldman | Neutral → Sell |
2019-04-02 | Aggiornamento | Jefferies | Hold → Buy |
2019-03-18 | Ripresa | Credit Suisse | Neutral |
2019-01-31 | Downgrade | Argus | Buy → Hold |
2019-01-17 | Iniziato | UBS | Neutral |
2019-01-03 | Downgrade | BofA/Merrill | Neutral → Underperform |
2018-12-03 | Downgrade | BofA/Merrill | Buy → Neutral |
2018-11-30 | Downgrade | Goldman | Buy → Neutral |
Mostra tutto
Quest Diagnostics Inc Borsa (DGX) Ultime notizie
Quest Diagnostics Incorporated (NYSE:DGX) Position Boosted by UMB Bank n.a. - MarketBeat
Short Interest in Quest Diagnostics Incorporated (NYSE:DGX) Increases By 6.3% - MarketBeat
9,488 Shares in Quest Diagnostics Incorporated (NYSE:DGX) Bought by Avanza Fonder AB - MarketBeat
DGX (Quest Diagnostics) Operating Income : $1,252 Mil (TTM As of Sep. 2024) - GuruFocus.com
Wedge Capital Management L L P NC Decreases Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Assenagon Asset Management S.A. Purchases 108,224 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Stock Position Raised by Occidental Asset Management LLC - MarketBeat
Miracle Mile Advisors LLC Takes $291,000 Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics (DGX) Stock Price, News & Analysis - MarketBeat
Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare - Yahoo Finance
Earnings Preview: What to Expect From Quest Diagnostics' Report - MSN
Revenue Cycle Management (RCM) Market Size is Expected to Reach USD 873.74 by 2033, Growing at a CAGR of 11%: Straits Research - GlobeNewswire Inc.
Sawyer & Company Inc Sells 2,168 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Gets Meta Data-Share Suit Tossed For Now - Law360
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Quest Diagnostics Wins Dismissal of Suit Over Meta Info Sharing - Bloomberg Law
Earnings Preview: What To Expect From Quest Diagnostics' Report - Barchart
Oak Thistle LLC Increases Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics (NYSE:DGX) Downgraded by StockNews.com to "Hold" - MarketBeat
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Clean Yield Group Purchases 3,983 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Relationship Genetic Tests Market Report 2024, Featuring - GlobeNewswire
Relationship Genetic Tests Market Report 2024, Featuring Profiles of Laboratory Corporation of America, Quest Diagnostics, Cleveland Clinic, Myriad Genetics, Invitae and More - Yahoo Finance
Zacks Research Has Bullish Outlook for DGX FY2025 Earnings - MarketBeat
Ex-Dividend Reminder: Universal Corp, Shoe Carnival and Quest Diagnostics - Nasdaq
Alzheimer's Disease Diagnostics Research Report 2024-2034: Global Market to Reach $27.87 Billion - GlobeNewswire Inc.
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Quest Diagnostics Employee Shares How Music Career Led to Healthcare Logistics Success - StockTitan
Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer - Financial Times
Nordea Investment Management AB Sells 13,456 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest Diagnostics (NYSE:DGX) Stock Rating Upgraded by Leerink Partnrs - MarketBeat
Quest Diagnostics Inc. stock rises Monday, still underperforms market - MarketWatch
Leerink Partners Upgrades Quest Diagnostics (DGX) - MSN
Quest Diagnostics (NYSE:DGX) Upgraded to "Outperform" at Leerink Partners - MarketBeat
Quest Diagnostics upgraded by Leerink Partners with a new price target - Quantisnow
Quest Diagnostics (NYSE:DGX) shareholders have earned a 9.4% CAGR over the last five years - Simply Wall St
Quest Diagnostics Inc. stock rises Friday, still underperforms market - MarketWatch
Why Quest Diagnostics (DGX) is Poised to Beat Earnings Estimates Again - Yahoo Finance
OhioHealth outsourcing some lab work to Quest Diagnostics - The Business Journals
Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025 - Longview News-Journal
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch
Should You Hold Quest Diagnostics Stock in Your Portfolio Now? - MSN
How Is Quest Diagnostics' Stock Performance Compared to Other Diagnostics & Research Stocks? - MSN
How Is The Market Feeling About Quest Diagnostics? - Benzinga
Short Interest in Quest Diagnostics Incorporated (NYSE:DGX) Declines By 6.4% - MarketBeat
JPMorgan Chase & Co. Sells 18,505 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Lobbying Update: QUEST DIAGNOSTICS INCORPORATED just disclosed $80,000 of lobbying spending - Nasdaq
Quest Diagnostics Incorporated (NYSE:DGX) Receives $169.15 Average PT from Brokerages - MarketBeat
Quest Diagnostics Inc. stock underperforms Friday when compared to competitors - MarketWatch
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Quest Diagnostics Inc Azioni (DGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):